These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 20007676)
21. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed]. Houillier P; Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626 [No Abstract] [Full Text] [Related]
22. Bone-vascular axis in chronic kidney disease: a reality? London GM Clin J Am Soc Nephrol; 2009 Feb; 4(2):254-7. PubMed ID: 19176792 [No Abstract] [Full Text] [Related]
23. [Insulin resistance and inflammation in chronic kidney diseases]. Guebre-Egziabher F; Kalbacher E; Fouque D Nephrol Ther; 2009 Jul; 5 Suppl 5():S346-52. PubMed ID: 19761971 [TBL] [Abstract][Full Text] [Related]
24. Lipid management in chronic kidney disease, hemodialysis, and transplantation. Montague T; Murphy B Endocrinol Metab Clin North Am; 2009 Mar; 38(1):223-34. PubMed ID: 19217521 [TBL] [Abstract][Full Text] [Related]
34. Kidney disease and cardiovascular disease: implications of dyslipidemia. Keane WF; Lyle PA Cardiol Clin; 2005 Aug; 23(3):363-72. PubMed ID: 16084284 [TBL] [Abstract][Full Text] [Related]
35. Pregnancy and contraceptive counseling of women with chronic kidney disease and kidney transplants. Watnick S Adv Chronic Kidney Dis; 2007 Apr; 14(2):126-31. PubMed ID: 17395115 [TBL] [Abstract][Full Text] [Related]
36. [Polygraphic studies before and after strophanthin therapy in subjects undergoing periodic dialytic treatment]. Pasqualicchio A; Pasoli CA; Franzoni A; Ancona G; Bruschi E; Gianfranceschi G Fracastoro; 1969; 62(1):21-5. PubMed ID: 5402907 [No Abstract] [Full Text] [Related]
37. Relation of amino acids, energy levels and protein synthesis in chronic renal disease. Metcoff J; Distler G; Weber R; Graser T; Schärer K; Fürst P; Schönberg D Child Nephrol Urol; 1988-1989; 9(3):153-9. PubMed ID: 3252964 [No Abstract] [Full Text] [Related]
38. Lipid metabolism and causal pathways for cardiovascular disease in chronic kidney disease. van Heyningen C Curr Opin Lipidol; 2009 Oct; 20(5):440-1. PubMed ID: 19741339 [No Abstract] [Full Text] [Related]
39. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Stubbs J; Liu S; Quarles LD Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819 [TBL] [Abstract][Full Text] [Related]
40. Renal disease and disorders of calcium metabolism. Kanis JA Compr Ther; 1978 Aug; 4(8):44-50. PubMed ID: 688743 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]